Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model - Concepedia

Concepedia

Publication | Closed Access

Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model

52

Citations

43

References

2006

Year

Liang Zhang, Xiaoping Zhang, Glen W. Barrisford, Aria F. Olumi

Trail-receptor 2ApoptosisImmunologyCell DeathPathologyImmune Checkpoint InhibitorAnti-cancer AgentTumor SuppressorMedicineMouse Orthotopic ModelTumor Biology

References

	Year	Citations

Page 1